aTyr Pharma
Edit

aTyr Pharma

http://www.atyrpharma.com/
Tags:BioTechDevelopmentEstateHumanInformationLifeProductPropertyPublicResearch
aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod (ATYR1923), a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in severe inflammatory lung diseases. For more information, please visit http://www.atyrpharma.com. The Company was founded by Professors Paul Schimmel, Ph.D., and Xiang-Lei Yang, Ph.D., two leading aminoacyl tRNA synthetase scientists at The Scripps Research Institute.
Likes
94
Location: United States, California, San Diego
Member count: 11-50
Phone: +1 858-731-8389
Total raised: $240.5M
Twitter
Facebook
LinkedIn
Email

Investors 5

Funding Rounds 7

DateSeriesAmountInvestorsDeal News
07.02.2023-$50M--
21.11.2016-$20M-socaltech....
01.04.2015Series E$76M-socaltech....
29.07.2013-$49M-finsmes.co...
26.10.2010Series C$23M-socaltech....
28.07.2009-$12M-socaltech....
18.04.2007-$10.5M-socaltech....

Mentions in press and media 78

DateTitleDescriptionCategoryAuthorSource
06.02.2023aTyr Pharm.../EIN News/ -- $10M milestone p...--einpresswi...
18.11.2022aTyr Pharm.../EIN News/ -- SAN DIEGO, Nov. ...--einpresswi...
25.10.2022aTyr Pharm...SAN DIEGO, Oct. 25, 2022 (GLOB...--globenewsw...
25.10.2022aTyr Pharm.../EIN News/ -- SAN DIEGO, Oct. ...--einpresswi...
13.09.2022aTyr Pharm.../EIN News/ -- Second Fast Trac...--einpresswi...
13.09.2022aTyr Pharm...Second Fast Track designation ...--globenewsw...
09.09.2022aTyr Pharm...SAN DIEGO, Sept. 09, 2022 (GLO...--globenewsw...
01.09.2022aTyr Pharm...SAN DIEGO, Sept. 01, 2022 (GLO...--globenewsw...
15.08.2022aTyr Pharm...First sites initiated in Phase...--globenewsw...
11.08.2022aTyr Pharm...SAN DIEGO, Aug. 11, 2022 (GLOB...--globenewsw...
Show more